Difference between revisions of "Part:BBa K2008005"

Line 3: Line 3:
 
<partinfo>BBa_K2008005 short</partinfo>
 
<partinfo>BBa_K2008005 short</partinfo>
  
This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A B. subtilis secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag (TD1, BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.
+
This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A <i>B. subtilis</i> secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag, TD1, (https://parts.igem.org/Part:BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.<br><br>
 
+
This coding sequence is under the control of the constitutive <i>B. subtilis</i> promoter pVeg (https://parts.igem.org/Part:BBa_K143012) and a strong <i>B. subtilis</i> RBS (https://parts.igem.org/Part:BBa_K780001).<br><br>
This coding sequence is under the control of the constitutive B. subtilis promoter pVeg (BBa_K143012) and a strong B. subtilis RBS (BBa_K780001).
+
 
+
 
+
 
Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry.
 
Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry.
  

Revision as of 19:23, 18 October 2016


pVeg->sec-TD1-KSCI-BBI

This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A B. subtilis secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag, TD1, (https://parts.igem.org/Part:BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.

This coding sequence is under the control of the constitutive B. subtilis promoter pVeg (https://parts.igem.org/Part:BBa_K143012) and a strong B. subtilis RBS (https://parts.igem.org/Part:BBa_K780001).

Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]